RxSight, Inc. (RXST)
NASDAQ: RXST · Real-Time Price · USD
7.32
-0.37 (-4.81%)
Mar 9, 2026, 1:16 PM EDT - Market open
RxSight Market Cap
RxSight has a market cap or net worth of $302.07 million as of March 9, 2026. Its market cap has decreased by -75.29% in one year.
Market Cap
302.07M
Enterprise Value
100.25M
1-Year Change
-75.29%
Ranking
Category
Stock Price
$7.32
Market Cap Chart
Since the IPO on July 30, 2021, RxSight's market cap has decreased from $424.33M to $302.07M, a decrease of -28.81%. That is a compound annual growth rate of -7.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 317.34M | -25.93% |
| Dec 31, 2025 | 428.44M | -69.08% |
| Dec 31, 2024 | 1.39B | -4.17% |
| Dec 29, 2023 | 1.45B | 311.68% |
| Dec 30, 2022 | 351.23M | 14.14% |
| Dec 31, 2021 | 307.73M | -27.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pacific Biosciences of California | 416.76M |
| Standard BioTools | 380.80M |
| Cerus | 370.89M |
| Viemed Healthcare | 338.93M |
| Delcath Systems | 315.50M |
| ClearPoint Neuro | 297.48M |
| TriSalus Life Sciences | 273.73M |
| Senseonics Holdings | 248.95M |